Acromegaly Community’s Acromegaly Patient-Focused Drug Development Meeting

Acromegaly Community Patient-Focused Drug Development Meeting April 28th, 2020 This Patient-Focused Drug Development meeting is designed as a convergence of critical FDA officials, acromegaly patients, pharmaceutical companies, and other relevant…

Continue Reading Acromegaly Community’s Acromegaly Patient-Focused Drug Development Meeting
Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
source: pixabay.com

Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA

On April 28th, 2020, Acromegaly Community, a nonprofit organization that is dedicated to supporting acromegaly patients, will be hosting a patient focused drug development meeting (PFDD). These meetings are an…

Continue Reading Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
Study Highlights Disparities Between Acromegaly Patients and Their Doctors
source: pixabay.com

Study Highlights Disparities Between Acromegaly Patients and Their Doctors

According to a story from Medscape, a recent study published in the medical journal Pituitary has revealed a significant disconnect between acromegaly patients and their physicians. The study suggests that doctors…

Continue Reading Study Highlights Disparities Between Acromegaly Patients and Their Doctors
The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
peter-facebook / Pixabay

The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials

According to a story from Markets Insider, the biopharmaceutical company Camurus has recently issued an announcement indicating that the US Food and Drug Administration (FDA) has accepted the company's Investigational…

Continue Reading The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials

First Human Study of ‘Robotic’ RaniPill Designed to Replace Injections of Biological Drugs

Most biological drugs, including insulin, can't be taken orally, because enzymes and proteins cause the drugs to break down too quickly in the digestive system. For decades, the pharma industry…

Continue Reading First Human Study of ‘Robotic’ RaniPill Designed to Replace Injections of Biological Drugs
Take a Walk – and a Selfie! – in Your Shoes for Acromegaly Awareness Day
Source: Pixabay.com

Take a Walk – and a Selfie! – in Your Shoes for Acromegaly Awareness Day

November 1st is Acromegaly Awareness Day! What is Acromegaly? Acromegaly is a hormonal disorder characterized by significant, abnormal growth, caused by an excess amount of growth hormone, or GH. GH is produced…

Continue Reading Take a Walk – and a Selfie! – in Your Shoes for Acromegaly Awareness Day
Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
Source: Pixabay

Midatech Pharma Gets Verbal Approval For MTD201 Continued Development

Midatech Pharma just received verbal confirmation from Polish regulators to conduct the first European in-human study for a treatment that could potential aid those with carcinoid cancer and acromegaly, reported…

Continue Reading Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
Close Menu